Justchymo-Forte Tablet contains Trypsin Chymotrypsin (100000 AU), a potent proteolytic enzyme combination widely used for its anti-inflammatory, anti-edematous, and fibrinolytic properties. This medication is primarily indicated for the management of acute and chronic inflammatory conditions, including postoperative swelling, trauma-related edema, and soft tissue injuries. Trypsin and chymotrypsin facilitate the breakdown of proteinaceous debris and fibrin deposits at the site of inflammation, thereby promoting faster resolution of swelling and pain. The enzymatic action also enhances microcirculation and accelerates tissue repair processes. Justchymo-Forte is beneficial as an adjunct therapy in conditions such as arthritis, phlebitis, and cellulitis, where inflammation and edema contribute to patient discomfort and delayed healing. It is typically administered orally, with dosage tailored according to the severity of the condition and patient response. The drug is generally well-tolerated, with minimal adverse effects; however, hypersensitivity reactions may occur in sensitive individuals. Caution is advised in patients with bleeding disorders or those on anticoagulant therapy, as the enzyme activity may influence coagulation parameters. Overall, Justchymo-Forte Tablet offers an effective therapeutic option for reducing inflammation and enhancing recovery in various clinical scenarios involving tissue injury and inflammation.

Dosage & How to Use